Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine
Conditions: Patient Satisfaction; Patient Preference; Quality of Life; Acceptability of Health Care Intervention: Sponsors: Pontificia Universidad Catolica de Chile; ViiV Healthcare Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2023 Category: Research Source Type: clinical trials